ALLOSTIMULATION OF PATIENTS LYMPHOCYTES GENERATES BOTH T-LIKE AND NK-LIKE CELLS CYTO-TOXIC FOR AUTOLOGOUS MELANOMA

被引:22
作者
BALSARI, A
FOSSATI, G
TARAMELLI, D
TONA, G
DELIA, D
GIARDINI, R
PARMIANI, G
机构
[1] IST NAZL STUDIO & CURA TUMORI, DIV EXPT ONCOL D, VIA VENEZIAN 1, I-20133 MILAN, ITALY
[2] IST NAZL STUDIO & CURA TUMORI, DIV EXPTL ONCOL A, I-20133 MILAN, ITALY
[3] IST NAZL STUDIO & CURA TUMORI, DIV PATHOL, I-20133 MILAN, ITALY
[4] UNIV MILAN, INST MED MICROBIOL, I-20122 MILAN, ITALY
关键词
D O I
10.1038/bjc.1985.151
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Killing of autologous melanoma (auto-Me) was obtained with pooled allostimulated peripheral blood lymphocytes (PBL) in 34/42 cases and found not to be due to a cross-reactivity between melanoma and allogeneic normal antigens. To see whether generation of tumor cytotoxic PBL by allostimulation was due to release of IL[interleukin]-2, PBL from 34 patients were divided into 2 aliquots and stimulated either by alloantigens or IL-2. Allostimulated PBL were cytotoxic for auto-Me in 30/34 cases (85%) whereas IL-2 generated tumor cytotoxic cells in 22/34 cases (64%). Lysis of K562, a target for monitoring NK-like activity, was obtained in 95-100% of cases with both stimuli. A similar frequency of OKT3+, OKT4+, OKT8+ and HNK1+ cells was found in PBL activated by allostimulation and IL-2, whereas a higher frequency of OKM1+ cells was evident in IL-2-stimulated PBL. Cold-target competition studies indicated that allostimulation generated at least 2 different types of effectors, 1 lytic to auto-Me but not to K562, and the other which lysed both targets. Allostimuated, FACS-separated T3- cells killed both auto-Me and K562 cells whereas T3+ cells lysed only auto-Me. It is concluded that allostimulation generated 2 subpopulations of auto-Me killer cells, 1 of the T lineage and the other NK-like, which both can destroy auto-Me targets.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 29 条
  • [1] ANICHINI A, 1985, INT J CANCER
  • [2] DEVRIES JE, 1984, J IMMUNOL, V132, P510
  • [3] FOSSATI G, 1982, CANCER IMMUNOL IMMUN, V14, P99
  • [4] PRIMARY BUT NOT METASTATIC HUMAN MELANOMAS EXPRESSING DR ANTIGENS STIMULATE AUTOLOGOUS LYMPHOCYTES
    FOSSATI, G
    TARAMELLI, D
    BALSARI, A
    BOGDANOVICH, G
    ANDREOLA, S
    PARMIANI, G
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1984, 33 (05) : 591 - 597
  • [5] GREENBERG PD, 1981, J IMMUNOGENET, V8, P493
  • [6] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES
    GRIMM, EA
    MAZUMDER, A
    ZHANG, HZ
    ROSENBERG, SA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) : 1823 - 1841
  • [7] HLA-DR HISTOCOMPATIBILITY LEUKOCYTE ANTIGENS PERMIT CULTURED HUMAN-MELANOMA CELLS FROM EARLY BUT NOT ADVANCED DISEASE TO STIMULATE AUTOLOGOUS LYMPHOCYTES
    GUERRY, D
    ALEXANDER, MA
    HERLYN, MF
    ZEHNGEBOT, LM
    MITCHELL, KF
    ZMIJEWSKI, CM
    LUSK, EJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (01) : 267 - 271
  • [8] HURRELL SM, 1983, J IMMUNOL, V131, P1017
  • [9] EXPRESSION OF H-2B ALLOANTIGENS IN A VARIANT OF A MOLONEY VIRUS-INDUCED YAC (H-2A) LYMPHOMA
    KEDAR, E
    SCHWARTZBACH, M
    KLEIN, E
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (09): : 861 - 865
  • [10] KEDAR E, 1982, POTENTIAL ROLE T CEL, P173